Form 8-K - Current report:
SEC Accession No. 0001193125-22-167356
Filing Date
2022-06-03
Accepted
2022-06-03 16:27:07
Documents
12
Period of Report
2022-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d354869d8k.htm   iXBRL 8-K 20947
  Complete submission text file 0001193125-22-167356.txt   141474

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220601.xsd EX-101.SCH 2533
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220601_lab.xml EX-101.LAB 18034
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220601_pre.xml EX-101.PRE 11325
6 EXTRACTED XBRL INSTANCE DOCUMENT d354869d8k_htm.xml XML 3449
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22994854
SIC: 2834 Pharmaceutical Preparations